Atlas Trials

Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients

Clinical trial NCT01278810 · UNKNOWN

Trial details

NCT number
NCT01278810
Sponsor
Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2010-11-01
Primary completion
2011-11-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.